# Short-course Radiotherapy Followed by Consolidation Chemotherapy. 2021-001206-29

> **NCT05253846** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Gruppo Oncologico del Nord-Ovest** · enrollment: 63 (estimated)

## Conditions studied

- Locally Advanced Rectal Cancer

## Interventions

- **DRUG:** Irinotecan
- **DRUG:** Oxaliplatin
- **DRUG:** Lederfolin
- **DRUG:** 5-Fluorouracil
- **RADIATION:** Short-course radiotherapy
- **PROCEDURE:** TME

## Key facts

- **NCT ID:** NCT05253846
- **Lead sponsor:** Gruppo Oncologico del Nord-Ovest
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-01-25
- **Primary completion:** 2025-01-05
- **Final completion:** 2028-10-30
- **Target enrollment:** 63 (ESTIMATED)
- **Last updated:** 2025-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05253846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05253846, "Short-course Radiotherapy Followed by Consolidation Chemotherapy. 2021-001206-29". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05253846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*